FDA Expands Aethlon Hemopurifier IDE To Address Ebola
This article was originally published in The Gray Sheet
Executive Summary
The agency approved an expanded clinical trial allowing Aethlon to test an Ebola treatment protocol at 10 U.S. sites; requires the company to gain institutional review board approval from each institution and the trials can only enroll up to 20 patients.